phramaceutical direct inc
about us
compliance and persistence programs
compliance and persistence programs
about us
co-op mailings to professionals
our clients
contact us
 




Patient non-compliance is a huge problem in the Pharma industry. On average, 34% of patients forget to take their medication and the average “monthly” prescription lasts for 43 days.

While particularly acute for asymptomatic conditions such as hypertension and high cholesterol, non-compliance is a problem that almost every product faces. This is an enormous loss of revenue.

Our PatientDirect™ Program attacks this problem head on. Using a novel, very effective compliance device called The Dose-Alert™ we can increase patient compliance by an average 34% at a cost of just $7.00 per patient. Think what a boost to your bottom line that would be!


While The Dose-Alert™ is a great product, it only works if you can put it right into the hands of your patients. And we can do it..

To do this we have combined forces with many of the major drug store chains who want to partner with you in this program. We then:

1. Package The Dose-Alert™ (along with a “Dear Valued Customer” letter extolling the benefits of compliance) in a bubble bag and ship to the mail distribution center of the drug chain.

2. They address and mail it to your patients. (We never see the patient names).

3. The drug store chain then prepares a report comparing the number of refills in the test group vs a demographically and numerically equivalent control group to determine the incremental revenue generated in the test group.

We make all of the arrangements. You don’t have to do anything except supply your logo artwork for the top of the cap.

Testing is easy and affordable.

For further details on the PatientDirect™ Program and the different ways to structure a program, contact the specialists at Pharmaceutical Direct at 973-927-0300 or email to info@pharmdirect.com

 
 

For more information on the Dose-Alert go to:
www.dose-alert.com